1. Home
  2. CVM vs OXBR Comparison

CVM vs OXBR Comparison

Compare CVM & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • OXBR
  • Stock Information
  • Founded
  • CVM 1983
  • OXBR 2013
  • Country
  • CVM United States
  • OXBR Cayman Islands
  • Employees
  • CVM N/A
  • OXBR N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • OXBR Property-Casualty Insurers
  • Sector
  • CVM Health Care
  • OXBR Finance
  • Exchange
  • CVM Nasdaq
  • OXBR Nasdaq
  • Market Cap
  • CVM 18.1M
  • OXBR 16.9M
  • IPO Year
  • CVM 1987
  • OXBR 2014
  • Fundamental
  • Price
  • CVM $9.45
  • OXBR $1.63
  • Analyst Decision
  • CVM
  • OXBR Strong Buy
  • Analyst Count
  • CVM 0
  • OXBR 1
  • Target Price
  • CVM N/A
  • OXBR $5.00
  • AVG Volume (30 Days)
  • CVM 2.0M
  • OXBR 123.8K
  • Earning Date
  • CVM 08-14-2025
  • OXBR 08-15-2025
  • Dividend Yield
  • CVM N/A
  • OXBR N/A
  • EPS Growth
  • CVM N/A
  • OXBR N/A
  • EPS
  • CVM N/A
  • OXBR N/A
  • Revenue
  • CVM N/A
  • OXBR $1,363,000.00
  • Revenue This Year
  • CVM N/A
  • OXBR $497.99
  • Revenue Next Year
  • CVM N/A
  • OXBR $42.14
  • P/E Ratio
  • CVM N/A
  • OXBR N/A
  • Revenue Growth
  • CVM N/A
  • OXBR N/A
  • 52 Week Low
  • CVM $1.98
  • OXBR $1.27
  • 52 Week High
  • CVM $39.30
  • OXBR $5.81
  • Technical
  • Relative Strength Index (RSI)
  • CVM 74.98
  • OXBR 37.78
  • Support Level
  • CVM $7.02
  • OXBR $1.77
  • Resistance Level
  • CVM $9.76
  • OXBR $2.06
  • Average True Range (ATR)
  • CVM 1.31
  • OXBR 0.25
  • MACD
  • CVM 0.45
  • OXBR -0.08
  • Stochastic Oscillator
  • CVM 86.62
  • OXBR 1.03

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

Share on Social Networks: